March 17, 2025 - 19:40

BELLINGHAM, Wash. — eXp World Holdings, Inc. has announced the appointment of Jesse Hill as the Interim Chief Financial Officer, effective April 1, 2025. Hill, who currently serves as the Vice President of International Finance and Corporate Financial Planning & Analysis at eXp Realty, steps into this crucial role as the company undergoes a leadership transition.
The decision to appoint Hill reflects the company's commitment to maintaining a strong financial oversight during this period of change. As Interim CFO, he will be responsible for overseeing the financial operations and strategic planning of the organization, ensuring that eXp World Holdings continues to thrive in a competitive market.
Hill's extensive experience in finance and corporate strategy positions him well to guide the company through its current phase. The leadership team and board of directors express confidence in his ability to lead effectively during this transitional period, as the company prepares for future growth and innovation.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...